ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.590
-0.050 (-3.05%)
Apr 29, 2026, 11:55 AM EDT - Market open
ALX Oncology Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 16.37 | 17.57 | 22.41 | 48.82 | 363.67 | Upgrade
|
| Short-Term Investments | 28.42 | 110.19 | 160.33 | 217.39 | - | Upgrade
|
| Cash & Short-Term Investments | 44.79 | 127.76 | 182.74 | 266.21 | 363.67 | Upgrade
|
| Cash Growth | -64.94% | -30.09% | -31.36% | -26.80% | -16.25% | Upgrade
|
| Other Receivables | 0.3 | 0.89 | 1 | - | - | Upgrade
|
| Receivables | 0.3 | 0.89 | 1 | - | - | Upgrade
|
| Prepaid Expenses | 5.62 | 5.68 | 4.49 | 4.76 | 3.35 | Upgrade
|
| Other Current Assets | 0.02 | 0.03 | 0.44 | - | - | Upgrade
|
| Total Current Assets | 50.73 | 134.35 | 188.66 | 270.97 | 367.02 | Upgrade
|
| Property, Plant & Equipment | 3.87 | 9.63 | 10.84 | 9.81 | 3.47 | Upgrade
|
| Long-Term Investments | 3.49 | 3.52 | 35.41 | 16.7 | - | Upgrade
|
| Other Long-Term Assets | 0.95 | 0.27 | 7.64 | 9.01 | 9.69 | Upgrade
|
| Total Assets | 59.05 | 147.78 | 242.55 | 306.49 | 380.18 | Upgrade
|
| Accounts Payable | 4.91 | 4.5 | 8.59 | 8.07 | 3.76 | Upgrade
|
| Accrued Expenses | 10.55 | 9.26 | 15.44 | 10.79 | 9.6 | Upgrade
|
| Current Portion of Long-Term Debt | 5.22 | 0.44 | - | - | - | Upgrade
|
| Current Portion of Leases | 1.86 | - | - | - | 0.74 | Upgrade
|
| Other Current Liabilities | 2.01 | 4.3 | 11.97 | 9.46 | 1.19 | Upgrade
|
| Total Current Liabilities | 24.55 | 18.5 | 36 | 28.33 | 15.3 | Upgrade
|
| Long-Term Debt | 4.53 | 9.47 | 9.64 | 9.39 | - | Upgrade
|
| Long-Term Leases | 3.16 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.82 | 6.19 | 7.2 | 5.31 | 1.84 | Upgrade
|
| Total Liabilities | 33.07 | 34.16 | 52.84 | 43.03 | 17.13 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 748.72 | 734.41 | 675.68 | 589.74 | 564.99 | Upgrade
|
| Retained Earnings | -722.82 | -621.12 | -486.27 | -325.47 | -201.99 | Upgrade
|
| Comprehensive Income & Other | 0.03 | 0.28 | 0.26 | -0.85 | - | Upgrade
|
| Total Common Equity | 25.98 | 113.62 | 189.71 | 263.46 | 363.05 | Upgrade
|
| Shareholders' Equity | 25.98 | 113.62 | 189.71 | 263.46 | 363.05 | Upgrade
|
| Total Liabilities & Equity | 59.05 | 147.78 | 242.55 | 306.49 | 380.18 | Upgrade
|
| Total Debt | 14.77 | 9.9 | 9.64 | 9.39 | 0.74 | Upgrade
|
| Net Cash (Debt) | 30.02 | 117.85 | 173.1 | 256.82 | 362.93 | Upgrade
|
| Net Cash Growth | -74.53% | -31.91% | -32.60% | -29.24% | -16.42% | Upgrade
|
| Net Cash Per Share | 0.56 | 2.26 | 4.03 | 6.31 | 9.00 | Upgrade
|
| Filing Date Shares Outstanding | 131.61 | 53.38 | 50.15 | 40.86 | 40.63 | Upgrade
|
| Total Common Shares Outstanding | 54.39 | 53.05 | 49.95 | 40.86 | 40.59 | Upgrade
|
| Working Capital | 26.17 | 115.85 | 152.66 | 242.64 | 351.72 | Upgrade
|
| Book Value Per Share | 0.48 | 2.14 | 3.80 | 6.45 | 8.94 | Upgrade
|
| Tangible Book Value | 25.98 | 113.62 | 189.71 | 263.46 | 363.05 | Upgrade
|
| Tangible Book Value Per Share | 0.48 | 2.14 | 3.80 | 6.45 | 8.94 | Upgrade
|
| Machinery | 2.47 | 2.47 | 2.31 | 1.93 | 0.73 | Upgrade
|
| Leasehold Improvements | 0.71 | 2.51 | 2.51 | 2.36 | 0.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.